Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |